Cargando…
Recent developments in MOG-IgG associated neurological disorders
In the past few years, acquired demyelinating syndromes of the central nervous system associated with antibodies against myelin oligodendrocyte glycoprotein (MOG) have evolved into a new inflammatory disease entity distinct from neuromyelitis optica spectrum disorders or multiple sclerosis. The meti...
Autores principales: | Hegen, Harald, Reindl, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521831/ https://www.ncbi.nlm.nih.gov/pubmed/33029200 http://dx.doi.org/10.1177/1756286420945135 |
Ejemplares similares
-
Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report
por: Liu, Pei, et al.
Publicado: (2020) -
Distinct features distinguishing IgG4-related disease from multicentric Castleman’s disease
por: Sasaki, Takanori, et al.
Publicado: (2017) -
MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020) -
Post-infectious neurological disorders
por: Blackburn, Kyle M., et al.
Publicado: (2020) -
Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis
por: Yan, Songxin, et al.
Publicado: (2022)